Summary
The effects of 1 week of treatment with low and moderate doses of verapamil or nifedipine upon platelet function has been studied in 12 healthy volunteers.
The ex vivo platelet aggregation threshold for ADP or adrenaline was not altered by verapamil or nifedipine. The plasma concentrations of β-thromboglobulin and platelet factor 4 were significantly reduced by low but not by moderate doses of verapamil and nifedipine.
Low doses of verapamil and nifedipine inhibit in vivo platelet activity in healthy volunteers.
This is a preview of subscription content, log in via an institution to check access.
References
De Clerck F (1986) Blood platelets in human essential hypertension. Agents Actions 18: 563–580
Erne P, Resnik TJ, Bürgisser E, Bühler FR (1985) Platelets and hypertension. J Cardiovasc Pharmacol 7 [Suppl 6]: 103–108
Tokahara K, Kuroiwa A, Matsushima T, Nakashima Y, Takasugi M (1985) Effects of nifedipine on platelet function. Am Heart J 109: 4–8
Jones CR, Pasanisi F, Elliott HL, Reid JL (1985) Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. Br J Clin Pharmacol 20: 191–196
Murphy MB, Orchard MA, Conway EL, Barrow SE (1985) The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF-1-alpha and its interaction with indomethacin. Eur J Clin Pharmacol 29: 413–416
Johnson GJ, Leis LA, Francis GS (1986) Disparate effects of the calcium-channel blockers, nifedipine and verapamil on alpha2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Circulation 73: 847–854
Winther K, Knudsen JB, Gormsen J, Jensen J (1986) Effect of metoprolol and propranolol on platelet aggregation and cAMP level in hypertensive patients. Eur J Clin Pharmacol 29: 561–564
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194: 927–929
Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD (1975) The release of human platelet specific protein measured by a radioimmunoassay. Thromb Res 6: 543–548
Handin RI, McDonough M, Lesch M (1978) Elevation of platelet factor four in acute myocardial infarction: measurement by radioimmunoassay. J Lab Clin Med 91: 340–349
Kiyomoto A, Soouki Y, Odawara A, Morita T (1983) Inhibition of platelet aggregation by diltiazem, comparison with verapamil and nifedipine and inhibitory potency of diltiazem metabolites. Circ Res 52 [Suppl 1]: 115–119
Glusa E, Bevan J, Heptinstall S (1989) Verapamil is a potent inhibitor of 5-HT-induced platelet aggregation. Thromb Res 55: 239–245
Yamanishi J, Sano H, Saito K, Furuta Y, Fukuzaki H (1985) Plasma concentrations of platelet-specific proteins in different stages of essential hypertension; interactions between platelet aggregation, blood lipids and age. Thromb Haemost 54: 539–543
Fritschka E, Distler A, Leutz T, Kribben A, Schudrowitsch L, Philipp TH (1984) Effect of nifedipine and verapamil on alpha receptor-activation in patients with essential hypertension. J Hypertension 2 [Suppl 3]: 535–538
Muiesan G, Agabiti-Rosei E, Romanelli G, Muesian ML, Castellano M, Beschi M (1986) Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists. Am J Cardiol 57: 44D-49D
Addonizio VP, Vetsvan L, Fischer CA, Foldman P, Strauss JF, Hanker H (1982) Mediation of cardiac ischaemia by thromboxane released by human platelets. Surgery 92: 1298–1299
Tofler GH, Brezinski D, Schafter AI (1987) Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316: 1514–1518
Kawahara J, Sano H, Fukuzaki H, Saito K, Kirovchi H (1989) Acute effects of exposure to cold on blood pressure, platelet function and sympathetic nervous activity in human. Am J Hypertension 2: 724–726
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winther, K., Jespersen, C.M., Rydberg, B. et al. Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteers. Eur J Clin Pharmacol 39, 291–293 (1990). https://doi.org/10.1007/BF00315114
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00315114